ABSTRACT NUMBER: ESOC2026A313 CILOSTAZOL FOR SECONDARY PREVENTION OF STROKE AND COGNITIVE DECLINE: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS

Eur Stroke J · 2026 · PMC13145486

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It did not improve MMSE scores (SMD -0.21[-0.33, -0.08]), largely driven by one large secondary analysis, but showed a trend towards reduced cognitive deterioration (RR 0.89[0.73,1.09]) and improved mood (SMD -0.16 [-0.40,0.08]).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.